Immunology and Microbiology
Vaccine Efficacy
100%
Influenza Vaccine
96%
Influenza
90%
Virus Inactivation
55%
Immune Response
50%
Influenza Virus
43%
Adjuvant
42%
Virosome
38%
Mouse
32%
Cytotoxic T Cell
27%
T Cell
26%
Vaccination Policy
23%
Humoral Immunity
22%
Influenza A Virus (H1N1)
22%
Dendritic Cell
20%
Subunit Vaccine
20%
Antigen
18%
Antibody Response
15%
Toll-Like Receptor
14%
Viral Disease
14%
B Cell
14%
Monospecific Antibody
14%
T-Helper Cell
12%
Phosphoryl Lipid A
12%
Peripheral Blood Mononuclear Cell
12%
Virus Strain
12%
Human Papillomavirus Type 16
11%
MHC Class I
11%
Cross Protection
11%
Titer
10%
Adoptive Immunity
10%
Nucleoprotein
9%
Viral Protein
9%
Dry Powder
9%
Enterobacteria Phage M13
9%
Surface Property
9%
Solution and Solubility
9%
Cotton Rat
9%
Immunogenicity
9%
Microorganism
9%
Memory B Cell
9%
Antibody Production
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Cell Proliferation
9%
Peripheral Blood Mononuclear Cell
9%
Antibody Titer
8%
Adaptive Immune System
8%
Neutralizing Antibody
8%
Antigen-Presenting Cell
7%
Antigen Specificity
7%
Pharmacology, Toxicology and Pharmaceutical Science
Influenza Vaccine
71%
Adjuvant
54%
Live Attenuated Influenza Vaccine
36%
Virosome
28%
Influenza Virus
27%
Saponin
25%
Subunit Vaccine
24%
Mouse
22%
Antigen
22%
Immunogenicity
19%
Virus Infection
16%
Powder Formulation
16%
Infection
14%
Respiratory Tract Infection
12%
Respiratory Tract
12%
Phosphoryl Lipid A
12%
Vaccination Policy
12%
Disease
10%
Immunoglobulin A
9%
Trehalose
9%
Mucosal Vaccine
9%
Pullulan
9%
Neoplasm
9%
Human Papillomavirus Type 16
9%
Secretory Immunoglobulin
9%
Nucleoprotein
9%
Cotton Rat
9%
Bagg Albino Mouse
9%
Viral Protein
9%
Bioassay
9%
Influenza A Virus (H1N1)
9%
Antivirus Agent
9%
Toll Like Receptor
6%
Liquid Formulation
6%
Dry Powder Inhaler
6%
Uterine Cervix Cancer
5%
Antibodies
5%
Keyphrases
Influenza Vaccine
40%
Cotton Rat
19%
Immune Response
16%
Lung
15%
Influenza
12%
Virus
12%
A(H1N1)pdm09
12%
Whole Inactivated Virus
11%
Influenza Virus
10%
Humoral Immune Response
10%
β-cell Proliferation
9%
Protective Efficacy
9%
Pulmonary Delivery
9%
Antibody Production
9%
Antigen-specific T Cell Response
9%
Powder Formulation
9%
Saponin Adjuvant
9%
Vaccine Formulation
9%
Memory B Cells
9%
Adjuvantation
9%
Booster Vaccination
9%
Protection Level
9%
Vaccine Dose
9%
Sequential Vaccination
9%
UV-C Disinfection
9%
Human Peripheral Blood
9%
Vaccine Evaluation
9%
Cell-based
9%
Peripheral Blood Mononuclear Cells
9%
Dissolving Microneedle Array
9%
Antigenic Seniority
9%
Novel Influenza Virus
9%
Evaluation System
9%
Memorials
9%
T Cells
8%
Intramuscular Immunization
7%
Antibody Response
6%
Immunogenicity
6%
Vaccine Adjuvant
6%
Antigen-specific
6%
Pulmonary Route
6%
Liquid Formulation
6%
Virus Growth
6%
Toll-like
6%
Mucosal Immune Response
6%
Systemic Immune Response
6%
Immunization
5%
Weight Loss
5%
